Product Description
Bisoprolol is used alone or in combination with other medications to treat high blood pressure. Bisoprolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve and decrease blood pressure. (Sourced from: https://medlineplus.gov/druginfo/meds/a693024.html)
Mechanisms of Action: ADRB1 Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: Merck KGaA
Company Location: GERMANY HRB 6164 I8
Company CEO: Belen Garijo
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: China
Active Clinical Trial Count: 4
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Angina Pectoris|Angina, Stable|Coronary Disease|Healthy Volunteers|Heart Failure, Chronic|Heart Failure, Systolic|Hypertension
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT05930808 |
Darmstadt-Nantong | P1 |
Completed |
Healthy Volunteers |
2023-06-18 |
2023-08-03 |
Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
|
CTR20230391 |
CTR20230391 | P1 |
Active, not recruiting |
Angina, Stable|Hypertension|Heart Failure, Chronic|Angina Pectoris|Heart Failure, Systolic|Coronary Disease |
None |
2025-04-29 |
Patient Enrollment|Start Date|Treatments|Trial Status |
|
CTR20231792 |
CTR20231792 | P1 |
Active, not recruiting |
Hypertension |
None |
2025-04-29 |
Patient Enrollment|Start Date|Treatments|Trial Status |
|
CTR20231791 |
CTR20231791 | P1 |
Not yet recruiting |
Hypertension |
None |
2025-04-29 |
Patient Enrollment|Treatments |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
10/04/2023 |
News Article |
Cell Phone Batteries Market - by Component, Type, Enterprise Size, Application, End-use Industry, and Region - to 2030 |
|
09/25/2023 |
News Article |
Road Haulage Market 360-Degree Research With Current and Future Trends |
|
09/21/2023 |
News Article |
Global Yoghurt and Sour Milk Drinks Market Size, Trends & Opportunities, Research Report 2023 -2031 |
|
09/19/2023 |
News Article |
Global Laboratory Consumables Market Insights Report 2023-2031 |